Skip to main content
Clinical Trials/NCT04811183
NCT04811183
Withdrawn
Not Applicable

Pharmaceutical Consultation and Exchange Between the Pharmacy and the Hospital

Hospices Civils de Lyon1 site in 1 country100 target enrollmentJune 23, 2023
ConditionsDiabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes
Sponsor
Hospices Civils de Lyon
Enrollment
100
Locations
1
Primary Endpoint
Evolution in the adherence
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

Investigators hypothesize that the implementation of a hospital pharmacy consultation and the transmission of its report to pharmacies may improve knowledge, adherence and encourage the development of pharmacist medication reviews. A before-and-after study of the implementation of pharmaceutical consultations will allow the investigators to evaluate the validity of the hypothesis.

Registry
clinicaltrials.gov
Start Date
June 23, 2023
End Date
June 23, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patient admitted in the endocrinology service for a type 2 Diabetes who has more than 5 concomitant treatments
  • Adult patient that is being discharged for a return home
  • Good comprehension of French

Exclusion Criteria

  • Bad comprehension of French

Outcomes

Primary Outcomes

Evolution in the adherence

Time Frame: One week

Evaluation of the patient's adherence to his treatment through a questionnaire giving a score between 0 to 6 -the higher the score, the better the outcome-. Comparison of the scores between the first questionnaire conducted during the pharmaceutical consultation and the second questionnaire one week after the consultation. Statistical evaluation by comparative tests between the two questionnaires.

Evolution in the knowledge about the patient's condition

Time Frame: One week

Treatment knowledge, knowledge about the pathology and knowledge of hygienic and dietary measures will be assessed with a questionnaire giving a score from 0 to 2 -the higher the score, the better the outcome-. Comparison of the knowledge of the treatment between the first questionnaire conducted during the pharmaceutical consultation and the second questionnaire one week after the consultation. Statistical evaluation by comparative tests between the two questionnaires.

Study Sites (1)

Loading locations...

Similar Trials